CAST Vaccine Development Issue Paper FINAL REV153
CAST Vaccine Development Issue Paper FINAL REV153
CAST Vaccine Development Issue Paper FINAL REV153
May 2008
This material is based upon work supported by the United States Department of Agriculture under Grant No. 2005-38902-02319, Grant No. 2006-38902-03539,
and Grant No. 2007-31100-06019/ISU Project No. 413-40-02. Any opinions, findings, conclusions, or recommendations expressed in this publication are those
of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture or Iowa State University.
CAST Issue Paper 38 Task Force Members
Authors Robert Silva, Avian Disease and Ronald D. Schultz, School of
Oncology Laboratory, USDA–ARS, Veterinary Medicine, University of
Mark W. Jackwood (Chair), Poultry East Lansing, Michigan Wisconsin–Madison
Diagnostic and Research Center,
University of Georgia, Athens Reviewers CAST Liaison
Leslie Hickle, Synthetic Genomics, Klaus Osterrieder, College of Vet- Alan W. Bell, CSIRO Livestock
Inc., La Jolla, California erinary Medicine, Cornell University, Industries, St. Lucia, Queensland,
Sanjay Kapil, Oklahoma Animal Ithaca, New York Australia
Disease Diagnostic Laboratory, Christopher Prideaux, CSIRO
Center for Veterinary Health Sci- Livestock Industries, St. Lucia,
ences, Oklahoma State University, Queensland, Australia
Stillwater
Technical Bulletin No. 1902, 121 pp. Reimann, I., G. Meyers, and M. Beer. 2003. Trans- tial ELISAs. J Vet Diagn Invest 5:347–350.
Nobiron, I., I. Thompson, J. Brownlie, and M. E. complementation of autonomously replicat- Uzzau, S., G. Marogna, G. S. Leori, R. Curtiss, III,
Collins. 2003. DNA vaccination against bovine ing bovine viral diarrhea virus replicons with G. Schianchi, B. A. Stocker, and S. Rubino.
viral diarrhoea virus induces humoral and deletions in the E2 coding region. Virology 2005. Virulence attenuation and live vaccine
cellular responses in cattle with evidence for 307:213–227. potential of aroA, crp cdt cya, and plasmid-
protection against viral challenge. Vaccine Rodriguez, F. and J. L. Whitton. 2000. Enhancing cured mutants of Salmonella enterica serovar
21:2082–2092. DNA immunization. Virology 268:233–238. Abortusovis in mice and sheep. Infect Immun
Oshop, G. L., S. Elankumaran, V. N. Vakharia, and Rogel, A., L. Benvenisti, I. Sela, O. Edelbaum, E. 73:4302–4308.
R. A. Heckert. 2003. In ovo delivery of DNA to Tanne, Y. Shachar, Y. Zanberg, T. Gontmakher, Vassilev, V. B., L. H. Gil, and R. O. Donis. 2001.
the avian embryo. Vaccine 21:1275–1281. E. Khayat, and Y. Stram. 2003. Vaccination Microparticle-mediated RNA immunization
Paoletti, E. 1996. Applications of pox virus vectors with E. coli recombinant empty viral particles against bovine viral diarrhea virus. Vaccine
to vaccination: An update. Proc Natl Acad Sci of infectious bursal disease virus (IBDV) con- 19:2012–2019.
USA 93:11349–11353. fers protection. Virus Genes 27:169–175. Veits, J., D. Luschow, K. Kindermann, O. Werner,
Perez Filgueira, D. M., M. Mozgovoj, A. Wigdoro- Rydell, N., L. Stertman, and I. Sjoholm. 2005. Starch J. P. Teifke, T. C. Mettenleiter, and W. Fuchs.
vitz, M. J. Dus Santos, V. Parreno, K. Trono, microparticles as vaccine adjuvant. Expert Opin 2003. Deletion of the non-essential UL0 gene
F. M. Fernandez, C. Carrillo, L. A. Babiuk, Drug Deliv 2:807–828. of infectious laryngotracheitis (ILT) virus leads
T, J. Morris, and M. V. Borca. 2004. Passive Schmidt, U., J. Beyer, U. Polster, L. J. Gershwin, to attenuation in chickens, and UL0 mutants
protection to bovine rotavirus (BRV) infec- and U. J. Buchholz. 2002. Mucosal immuniza- expressing influenza virus haemagglutinin (H7)
tion induced by a BRV VP8* produced in tion with live recombinant bovine respiratory protect against ILT and fowl plague. J Gen
plants using a TMV-based vector. Arch Virol syncytial virus (BRSV) and recombinant BRSV Virol 84:3343–3352.
149:2337–2348. lacking the envelope glycoprotein G protects Wesley, R. D. and K. M. Lager. 2006. Overcoming
Piller, K. J., T. E. Clemente, S. M. Jun, C. C. Petty, S. against challenge with wild-type BRSV. J Virol maternal antibody interference by vaccination
Sato, D. W. Pascual, and K. L. Bost. 2005. Ex- 76:12355–12359. with human adenovirus 5 recombinant viruses
pression and immunogenicity of an Escherichia Schynts, F., E. Baranowski, M. Lemaire, and E. expressing the hemagglutinin and the nucleo-
coli K99 fimbriae subunit antigen in soybean. Thiry. 1999. A specific PCR to differentiate protein of swine influenza virus. Vet Microbiol
Planta 222:6–18. between gE negative vaccine and wildtype 118:67–75.
Qiao, C. L., K. Z. Yu, Y. P. Jiang, Y. Q. Jia, G. bovine herpesvirus type 1 strains. Vet Microbiol Yoo, D., F. L. Graham, L. Prevec, M. D. Parker, M.
B. Tian, M. Liu, G. H. Deng, X. R. Wang, 66:187–195. Benko, T. Zamb, and L. A. 1992. Synthesis
Q. W. Meng, and X. Y. Tang. 2003. Protec- Streatfield, S. J. 2005. Plant-based vaccines for ani- and processing of the haemagglutinin-esterase
tion of chickens against highly lethal H5N1 mal health. Rev Sci Tech 24:189–199. glycoprotein of bovine coronavirus encoded
and H7N1 avian influenza viruses with a Swenson, S. L., J. McMillen, and H. T. Hill. 1993. in the E3 region of adenovirus. J Gen Virol
recombinant fowlpox virus co-expressing H5 Diagnostic compatibility of a thymidine kinase, 73(10):2591–2600.
haemagglutinin and N1 neuraminidase genes. inverted repeat, gI, and gpX modified live
Avian Pathol 32:25–32. gene-deleted PRV vaccine with three differen-
The mission of the Council for Agricultural Science and Technology (CAST) is to assemble, interpret, and communicate credible science-based informa-
tion regionally, nationally, and internationally to legislators, regulators, policymakers, the media, the private sector, and the public. CAST is a nonprofit organization
composed of 38 scientific societies and many individual, student, company, nonprofit, and associate society members. CAST’s Board of Directors is composed of represen-
tatives of the scientific societies and individual members, and an Executive Committee. CAST was established in 1972 as a result of a meeting sponsored in 1970 by the
National Academy of Sciences, National Research Council. ISSN 1070-0021
Additional copies of this issue paper are available from CAST. Linda M. Chimenti, Managing Scientific Editor. World WideWeb: http://www.cast-science.org.
Citation: Council for Agricultural Science and Technology (CAST). 2008. Vaccine Development Using Recombinant DNA Technology Issue Paper 38.
CAST, Ames, Iowa.